SCHEMBL9366393

SCHEMBL9366393

Cc1[nH]cnc1CC1CCc2c(c3cccc(F)c3n2C)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.43
KCNH2 Q12809 3/20 0.43
HTR2B P41595 3/20 0.43
CYP1A2 P05177 2/20 0.43
HTR3A P46098 2/20 0.43
HTR2A P28223 2/20 0.43
HTR2C P28335 2/20 0.43
ADRA2C P18825 1/20 0.43
ADRA1A P35348 1/20 0.43
CASP6 P55212 1/20 0.43
CYP2D6 P10635 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41
SLC22A3 O75751 1/20 0.41
HTR3B O95264 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL9596042 0.94 CYP3A4 (0.40) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Fumaric Acid SCHEMBL9596055 0.94 CYP3A4 (0.40) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Lurosetron SCHEMBL9244152 0.87 KCNH2 (0.68) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Galdansetron SCHEMBL4564582 0.84 KCNH2 (0.61) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Galdansetron SCHEMBL635736 0.84 KCNH2 (0.61) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Galdansetron SCHEMBL636713 0.83 CASP6 (0.62) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Galdansetron SCHEMBL9597123 0.82 CASP6 (0.61) CYP3A4KCNH2HTR2BCYP1A2HTR3A
SCHEMBL9596465 0.82 CYP3A4 (0.46) CYP3A4KCNH2HTR2BCYP1A2HTR3A
Hydrochloric Acid SCHEMBL7302142 0.79 CASP6 (0.40) CYP3A4KCNH2HTR2BCYP1A2HTR3A
SCHEMBL8962591 0.79 HSD17B10 (0.43) CYP3A4KCNH2HTR2BCYP1A2HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0345956-B1 Tricyclic ketones GLAXO GROUP LTD (GB) 1994-03-16 EP claimed
US-5202343-A Treating anxiety, psychological disorders GLAXO GROUP LIMITED (GB) 1993-04-13 US claimed
JP-2067280-A None JP disclosed
EP-0345956-B1 Tricyclic ketones GLAXO GROUP LTD (GB) 1994-03-16 EP disclosed
US-5202343-A Treating anxiety, psychological disorders GLAXO GROUP LIMITED (GB) 1993-04-13 US disclosed
JP-H0267280-A TRICYCLIC KETONE GLAXO GROUP LTD 1990-03-07 JP disclosed
EP-0345956-A1 Tricyclic ketones GLAXO GROUP LIMITED (GB) 1989-12-13 EP disclosed
US-4859662-A Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances GLAXO GROUP LIMITED (GB) 1989-08-22 US disclosed